These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 31885896)

  • 1. Ocular Surface Changes in Prostaglandin Analogue-Treated Patients.
    Shen W; Huang B; Yang J
    J Ophthalmol; 2019; 2019():9798272. PubMed ID: 31885896
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    DI Staso S; Agnifili L; Cecannecchia S; DI Gregorio A; Ciancaglini M
    In Vivo; 2018; 32(2):211-220. PubMed ID: 29475902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and Safety of Brinzolamide as Add-On to Prostaglandin Analogues or β-Blocker for Glaucoma and Ocular Hypertension: A Systematic Review and Meta-Analysis.
    Liu Y; Zhao J; Zhong X; Wei Q; Huang Y
    Front Pharmacol; 2019; 10():679. PubMed ID: 31293419
    [No Abstract]   [Full Text] [Related]  

  • 4. Efficacy and safety of different regimens for primary open-angle glaucoma or ocular hypertension: a systematic review and network meta-analysis.
    Li F; Huang W; Zhang X
    Acta Ophthalmol; 2018 May; 96(3):e277-e284. PubMed ID: 29144028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aqueous Prostaglandin Eye Drop Formulations.
    Jansook P; Loftsson T
    Pharmaceutics; 2022 Oct; 14(10):. PubMed ID: 36297577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of selected antihypertensives, antidiabetics, statins and diuretics on adjunctive medical treatment of glaucoma: a population based study.
    Iskedjian M; Walker JH; Desjardins O; Robin AL; Covert DW; Bergamini MV; Einarson TR
    Curr Med Res Opin; 2009 Aug; 25(8):1879-88. PubMed ID: 19530975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medical therapy for glaucoma: what to add after a prostaglandin analogs?
    Tanna AP; Lin AB
    Curr Opin Ophthalmol; 2015 Mar; 26(2):116-20. PubMed ID: 25594765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Balancing efficacy and tolerability of prostaglandin analogues and prostaglandin-timolol fixed combinations in primary open-angle glaucoma.
    Aptel F; Denis P
    Curr Med Res Opin; 2011 Oct; 27(10):1949-58. PubMed ID: 21878000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term assessment of prostaglandin analogs and timolol fixed combinations vs prostaglandin analogs monotherapy.
    Liu AW; Gan LY; Yao X; Zhou J
    Int J Ophthalmol; 2016; 9(5):750-6. PubMed ID: 27275435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative efficacy and tolerability of topical prostaglandin analogues for primary open-angle glaucoma and ocular hypertension.
    Lin L; Zhao YJ; Chew PT; Sng CC; Wong HT; Yip LW; Wu TS; Bautista D; Teng M; Khoo AL; Lim BP
    Ann Pharmacother; 2014 Dec; 48(12):1585-93. PubMed ID: 25184309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of glaucoma: focus on pharmacological therapy.
    Marquis RE; Whitson JT
    Drugs Aging; 2005; 22(1):1-21. PubMed ID: 15663346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A review of preserved and preservative-free prostaglandin analogues for the treatment of open-angle glaucoma and ocular hypertension.
    Hommer A
    Drugs Today (Barc); 2010 Jun; 46(6):409-16. PubMed ID: 20571609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does the intraocular pressure-lowering effect of prostaglandin analogues continue over the long term?
    Kara C; Şen EM; Elgin KU; Serdar K; Yilmazbaş P
    Int Ophthalmol; 2017 Jun; 37(3):619-626. PubMed ID: 27506567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glaucoma: a review of adjunctive therapy and new management strategies.
    Whitson JT
    Expert Opin Pharmacother; 2007 Dec; 8(18):3237-49. PubMed ID: 18035966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacology of topical prostaglandin F2 α analogs and their place in the treatment of glaucoma in small animals.
    Maślanka T
    J Vet Pharmacol Ther; 2015 Apr; 38(2):105-12. PubMed ID: 25230091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A meta-analysis of topical prostaglandin analogues intra-ocular pressure lowering in glaucoma therapy.
    Denis P; Lafuma A; Khoshnood B; Mimaud V; Berdeaux G
    Curr Med Res Opin; 2007 Mar; 23(3):601-8. PubMed ID: 17355741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preservative-free tafluprost 0.0015% in the treatment of patients with glaucoma and ocular hypertension.
    Erb C; Lanzl I; Seidova SF; Kimmich F
    Adv Ther; 2011 Jul; 28(7):575-85. PubMed ID: 21725844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Episcleral Venous Pressure and the Ocular Hypotensive Effects of Topical and Intracameral Prostaglandin Analogs.
    Lee SS; Robinson MR; Weinreb RN
    J Glaucoma; 2019 Sep; 28(9):846-857. PubMed ID: 31261285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of central corneal thickness on response to topical prostaglandin analogue therapy.
    Birt CM; Buys YM; Kiss A; Trope GE;
    Can J Ophthalmol; 2012 Feb; 47(1):51-4. PubMed ID: 22333852
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.